The practice of performing systematic biopsies in all men with elevated serum total prostate-specific antigen (PSA) levels causes unacceptable rates of over diagnosis and overtreatment of clinically insignificant prostate cancer (1). The gene discussed is KLK3; the disease is Familial prostate cancer.